Online
|
|
NSE Announcements on Piramal Life
Posted by :
MMB MessengerNews Verification : The media had reports of a possible takeover of Piramal Life Science Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Piramal Life Sciences Limited has vide its letter inter-alia stated,"The media report about the possible takeover of the company is totally unfounded."...
Okay I agree that these type of business would have its own gestation and time.However the global bust is changing all.See,El Lily cancelled a major clinical project with Glenmark worth $360 million.Yes,in USA so many hospitals are closing/under budgetary constraints..........soon the tap will run dry for funding these long type of projects.
Piramal life sciences does have clinical research projects in the pipeline,but they are producing nothing much,just no luck.Now what we see is just increasing losses.
Ok stock is on upper circuit,yes these games keep being played as before.Any sustained upmove, exit on the rise as I feel that by 2012 the company will melt to neat zero levels in the global meltdown.The only logical possibility for a rise is insider information that Glaxo or some global pharma major is buying up the company.I had been continously advising a sell from 260 upto 50 levels...........watch now and exit smartly on this rise.Good Luck on this unlucky counter....
Clinical research is a very expensive, high risk-high reward business.You are right in that revenues will come only when the product is approved for subscription.But the problem is whether they will be able to discover a molecule and whether it will be approved.Being a doctor,i can very categorically tell you that discovering a new drug and getting it approved by USFDA is not easy at all.It will take several years for the process to be complete and in the mean time losses will keep mounting.Piramal life already has a loss of 75 crore rupees in the past 9 months,let`s be too optomistic and assume that they do get a drug approved by 2012,by that time there accumulated loss will be minimum 450-500 crore rupees.Even if the drug gives them revenues of 500cr,it will come over 4-5 years,they will still continue to be in loss becoz expenses for new research will continue to mount.Now think what will happen if they get a drug but it fails at the last step of approval,all the money spent til then will make a huge hole in the balance sheet and the company could easily go bankrupt.Please note that it`s very difficult to get financing for such high risk businesses during recessionary times.Already many big MNCs in this business are suffering colossal losses.I myself bought the share at Rs305,but exited at 240,taking a loss.I felt I was very unlucky,but now I feel that I am actually lucky to sellor my entire capital would have been lost.Please do not buy into this counter even if somebody is offering at Re1.Big traders can easily manipulate such illiquid stocks,becoz you require only a few lakhs to make the stock hit its upper circuit.Dear retailers please dont fall into such traps,instead please EXIT EXIT EXIT with every rise....
You dont know about business of this company. They are into clinical research and revenues realize once the research is complete and product is approved for subscription. This company will start generating cash 2012 onward...if you buy at this price it will be minimum 10 times from here in 3 years period. ...
Exit on every upmove................just see on the day the stock was listed Mr Ajay Piramal came on CNBC saying that a reputed brokerage has assessed the stock around 750 and small investors brought in the range of 400-500 as per their posts.Stock listed at 540 and heavy selling took place seeing the volumes,by those who knew that severe losses would be posted in the forth-coming results.
I wonder any such game now?
P.S. Such games have to be played as folks have to cover their losses.Daily we see this....
Again pretty ugly losses as expected.Anyhow lets refresh though there is nothing refreshing here......only more increasing losses to come......also its heading to bankruptcy.
1)When the stock was at 260 I gave a clear-cut target of 160 on this board.2)I then gave my target at 120. 3)My next target was "Below 120"which was revised to "Below 100".4)I then revised the target to 60 levels and then to 50 levels which was then revised to "Below 20 levels" which will be attained soon.However my one year target(Dec 2009) now is "Below 10"
I had at all times given a call to exit with a caution not to re-enter as the gradual fall will take the stock to near zero levels.I also forecasted increasing losses for the next eight quarters at least.Yes,in fact,I am wondering,as I was expecting higher losses.See Glenmark,with a proven R&D arm has fallen by over 25% today after its insipid numbers.
From 200 levels my call has been to exit this stock at any level to whoever will buy it.I still mantain this call with a loud Exit call here.Exit!...
BSE Announcements on Piramal Life
Posted by : MMB MessengerPiramal Life Sciences Ltd has informed BSE about the Unaudited financial results for the Quarter ended December 31, 2008....
NSE Announcements on Piramal Life
Posted by : MMB MessengerPiramal Life Sciences Limited has informed the Exchange regarding a revised press release dated January 15, 2009, titled "Piramal Life Sciences initiates Phase II trials of P276 for Mantle Cell Lymphoma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
NSE Announcements on Piramal Life
Posted by : MMB MessengerPiramal Life Sciences Limited has informed the Exchange regarding a press release dated January 15, 2009, titled "Piramal Life Sciences initiates Phase II trials of P276 for Mantle Cell Lymphoma". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Piramal Life
Posted by : MMB MessengerPiramal Life Sciences Ltd has informed BSE regarding a Press Release dated January 15, 2009 titled "Piramal Life Sciences initiates Phase II trials of P276 for Mantle Cell Lymphoma"....
Yes awaiting the next quarterly results which will again show increasing ugly losses....................yes,just get out!...
